Clinical Trial Update: Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

View source ↗

Summary

Clinical trial update on the long-term use of Alogliptin/Pioglitazone (Liovel) combination tablets in adults with type 2 diabetes mellitus; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin/Pioglitazone (Liovel) Combination Tablets (Alogliptin Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2019-01-18